You are on page 1of 4

OMKAR PHARMACHEM LIMITED

CIN L24231 GJ1995PLC025276


501, Mahakant Building,
Opp. V.S. Hospital,
Ashram road, Ellisbridge,
Ahmedabad-380 006.
Website www.omkaruharmachem.co.in
Email investors.opl@gmaiI.com

Date: 13/02/2016
To,

Bombay Stock Exchange Limited,


Phiroz [eejeebhoy Towers,
Dalal Street,
Mumbai-400001

Sub: - Unaudited Quarterly Financial Result under Regulation 33 of the of the SEBI
(Listing Obligation And Disclosure Requirement) Regulation 2015. for the
Quarter ended 31st December. 2015
Company Scrip Code: 532167
Dear Sir,
Pursuant to the provisions of Regulation 33 of the of the SEBI (Listing Obligation And
Disclosure Requirement)
Regulation 2015, please find enclosed herewith, copy of the
Unaudited Quarterly Financial Results of the Company, for the Quarter ended 31st
December, 2015, for your kind perusal and reference.
The aforesaid result has been approved by the Board of Directors at their meeting held on
13th February, 2016.
This is for your information

and record.

Thanking You,
Yours faithfully,
For Omkar Pharmachem Limited

~~

(Anurag Sharma)
Managing Director
DIN 02289261
Add: A-727, Sarita Vihar, NewDelhi, 110076
Encl: a/a

OMKAR PHARMACHEM

LIMITED

Regd. Off. 501. Mahakant Bolding. opp: V.S. Hospital, Ashram Road. Ellisbridge. Ahmedabad-380006
elN:

L2423 I GJI995PLC025276

Statement

of Standalone

Unaudited

Website:

www.omkarphannachem.co.in

Results for the Quarter

Email: investors.opl@gmail.com

and Nine Months ended on 31st December

2015

(Rs in lacs except per sbare data)


Particulars

Quarter

(Refer notes Below)

Ended on

Nine Months

Ended on

Year ended on

31-12-2015

30-09-2015

31-12-2014

31-12-2015

31-12-2014

31-3-2015

(unaudited)

(unaudited)

(unaudited)

(unaudited)

(unaudited)

(audited)

1. Income from operations


a)Net Sales! Income from Operations

0.00

0.00

0.00

0.00

0.00

b)Other Operating Income

0.00

0.00

0.00

0.00

0.00

Total income from Operations

0.00

0.00

0.00

0.00

0.00

0.62
0.87
1.49

0.61
2.54

0.60
0.38

1.85

1.80

6.99

2.95

3.15

0.98

8.84

4.75

2.46
3.67
6.13

-3.15
0.00

-0.98
0.00

-8.84
0.00

-4.75

-6.13

0.00

-3.15
0.00

-0.98
0.00

-8.84
0.00

-4.75

-6.13

0.00

0.00

-3.15
0.00

-0.98

-8.84

-4.75

-6.13

0.00

0.00

0.00

0.00

-0.98

-6.13

-8.84
0

-4.75

-3.15
0

0.00

-1.49

-3.15

-0.98

-8.84

-4.75

-6.13

1008.37

1008.37

1008.37

1008.37

1008.37

1008.37

2. Expenses
a) Employee benefits expense
b) Other Expenses
Total Expenses
3. Profit(Loss)

from operations

Finance cost and exceptional


4. Other Income

before Other

income,
-l.49

items(I-2)

0.00

S. Profit(Loss) before Finance cost and exceptional


items(3+4)
6. Finance Costs
7. Profit(Loss)

from Ordinary

but before exceptionai


8. exceptional items
9. Profit(Loss)

Activities

-1.49
0.00

before Taxes
-1.49

items ( 5-6)

0.00

before Taxes( 5-6)

10. Tax Expence


Il.Net Profit(Loss)

0
0.00
0.00

-1.49

for the period (7-8)

12. Paid up Equity Share Capital (Face Value Rs. IO/-each)


13. Reserves excluding Revaluation Reserves as per
Balancesheet of previous year
14. Earning Per Share(before
& after extraordinary
items)(of Rs, 10 each)(not annualisedl
Basic and diluted Rs.
Notes:

I. The accountmg

standard

regardmg

segment

-81.00

-0.0148
reportmg

IS

-0.0312

not apphcable

-0.0877

-0.0097

to the company

-0.0471

as there IS no segment.

2. The above results have been reviewed by the audit committee & approved by the Board of Directors at there respective meetings held
on 13th February 2016. The statutory Auditors of the Company has carried out Limited Review of the aforesaid results.
3. Corrosponding

previous period figures are regrouped/rearranged

whereever necessary. to make them comparable.


By order of the Board

Date: 13-02-2016
Place: Ahmedabad

(Anurag Sharma) M.D.

-0.0608

OMKAR PHARMACHEM LIMITED


CIN L2423 t GJt 995PLC025276
sot, Mahakant Building,
Opp. V.S. Hospital,
Ashram road, Ellisbridge,
Ahmedabad-380 006.
Website www.omkarpharmachem.co.in
Email investors.opl@gmail.com

Date: 13/02/2016
To,

Bombay Stock Exchange Limited,


Phiroz [eejeebhoy Towers,
Dalal Street,
Mumbai-400001

Sub: Submission of Limited Review Report for the Quarter ended on 31st
December. 2015
Company Scrip Code: 532167
Dear Sir,
As per Regulation 33 of the of the SEBI (Listing Obligation And Disclosure Requirement)
Regulation 2015, please find enclosed herewith the Copy of the Limited Review Report
issued by M/s Rajesh J. Shah & Associates, Chartered Accountants, Statutory Auditors of
the Company on the Unaudited Quarterly Financial Results of the company, for the
period ending on 31st December, 2015.
Thanking You,
Yours faithfully,
For Omkar Pharmachem Limited

~~

(Anurag Sharma)
Managing Director
DIN 02289261
Add: A-727, Sarita Vihar, New Delhi, 110076
Encl: a/a

Rajesh

Shah & Associates


Chartered Accountants

Limited review report to The Board of Directors of Omkar Pharmachem Limited for
quarter ended on

l't December,

20 1 5

We have reviewed the accompanying statement of unaudited financial results of


Omkar Pharmachem Limited for the quarter ended on 31't December, 2015. This
statement is the responsibility of the Company's management and has been approved
by the Board of Directors. Our responsibility is to issue a report on these financial
statements based on our review.

We conducted our review in accordance with the Standard on Review Engagement


(SRE) 2400, Engagements to Review Financial Statements issued by the Institute of
Chartered Accountants of India. This standard requires that we plan and perform the
review to obtain moderate assurance as to whether the financial statements are free of
material misstatement. A review is limited primarily to inquiries of company
personnel and analytical procedures applied to financial data and; thus provides less
assurance than an audit. We have not performed an audit and accordingly, we do not
express an audit opinion.
Based on our review conducted as above, nothing has come to our notice that causes
us to believe that the accompanying statement of unaudited financial results prepared
in accordance with applicable accounting standards and other recognized accounting
practices and policies has not disclosed the information required to be disclosed in
terms
Regulation 33
the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 including the manner in which it is to be disclosed,
or that it contains any material misstatement.

of

of

For Rajesh J. Shah & Associates


Chartered Accountants

Place: Ahmedabad

Date:13102/2016

Partner

B-110-111, Gopal Palace, Opp. Ocean Park, Nr. Nehrunagar BRTS Stop, Nehrunagar-Satellite Road,Satellite, Ahmedabad-380015
Tel.No. 079-26760s37 126760637 126767637 M. No. (KBP) 94260 08343, (RJS) 98240 4s69s,
info@rajeshjshahca.com / rjshah_ca@yahoo.com www.rajeshjshahca.com / rajeshjshahassociates.icai,org.in

You might also like